コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 oding potassium voltage-gated channels and a muscarinic acetylcholine receptor.
2 volved in the recycling of the M4 subtype of muscarinic acetylcholine receptor.
3 of the inactive and active state of the M(3) muscarinic acetylcholine receptor.
4 402-421 in transmembrane helix 7 of the M(1) muscarinic acetylcholine receptor.
5 beta2 adrenergic receptor (hbeta2AR) and M2 muscarinic acetylcholine receptor.
6 ulated with type 1 protease activated and M1 muscarinic acetylcholine receptors.
7 etabotropic glutamate receptors (mGluRs) and muscarinic acetylcholine receptors.
8 ies of cysteine (Cys)-substituted mutant M 3 muscarinic acetylcholine receptors.
9 HVC activity and was attenuated by blocking muscarinic acetylcholine receptors.
10 a series of cysteine-substituted mutant M(3) muscarinic acetylcholine receptors.
11 er reaction and are allosteric modulators at muscarinic acetylcholine receptors.
12 d which is inhibited following activation of muscarinic acetylcholine receptors.
13 lated, and only weakly inhibited, through M1 muscarinic acetylcholine receptors.
14 phenotype can be rescued by an antagonist of muscarinic acetylcholine receptors.
15 ergic G protein-coupled receptors, including muscarinic acetylcholine receptors.
16 y acetylcholine acting on both nicotinic and muscarinic acetylcholine receptors.
17 y changes in glycolysis and by activation of muscarinic acetylcholine receptors.
18 while enhancing myelination by deleting the muscarinic acetylcholine receptor 1 in oligodendrocyte p
19 n upon stimulation with nafenopin, including muscarinic acetylcholine receptor 3, intermediate filame
20 , we find that the Chrm4 transcript encoding muscarinic acetylcholine receptor 4 (M4) is excessively
22 nergic, dopaminergic D3 and D4 receptors and muscarinic acetylcholine receptor 4, the receptor tyrosi
23 eviously undisclosed antagonists of the M(2) muscarinic acetylcholine receptor, a G-protein coupled r
24 Herein we address these topics for the M1 muscarinic acetylcholine receptor, a key molecular targe
26 ting to their active state, we used the M(3) muscarinic acetylcholine receptor, a prototypical class
29 HEK 293 cells was induced via recombinant M2 muscarinic acetylcholine receptors activated by carbacho
31 omain 3 (TM3) plays a crucial role mediating muscarinic acetylcholine receptor activation by acetylch
32 e rat dentate gyrus to examine the effect of muscarinic acetylcholine receptor activation on the intr
33 on the unknown transduction pathway linking muscarinic acetylcholine receptor activation to M-channe
34 rom intracellular stores and triggered by M1 muscarinic acetylcholine receptor activation was critica
37 ese results propose a new mechanism by which muscarinic acetylcholine receptors affect cognition and
39 bath application of 3 mum carbachol (CCh), a muscarinic acetylcholine receptor agonist, reduces evoke
43 study we have generated mice lacking the M1 muscarinic acetylcholine receptor and examined the effec
44 evaluating the binding sites of both the M2 muscarinic acetylcholine receptor and the D2 dopamine re
45 limiting the active conformation of the M(2) muscarinic acetylcholine receptor and thereby regulate s
46 ptor (LGR7), G-proteins (Galpha(q/11/o/13)), muscarinic acetylcholine receptor and vanilloid (TRPV1)
47 ure activation of recombinant and endogenous muscarinic acetylcholine receptors and activation of rec
48 ovary (CHO) cells stably transfected with M1 muscarinic acetylcholine receptors and currents were rec
49 an M(2)-selective competitive antagonist of muscarinic acetylcholine receptors and exhibits alloster
50 ugh a slowly activating pathway linked to M1 muscarinic acetylcholine receptors and Galphaq/11 protei
51 ular solution, indicating the involvement of muscarinic acetylcholine receptors and InsP(3)-sensitive
52 mechanism describing the interaction of M(2) muscarinic acetylcholine receptors and the guanine nucle
54 amine receptors, 5-HT (serotonin) receptors, muscarinic acetylcholine receptor, and adrenergic recept
55 .5 +/- 8.5% of controls), insensitive to the muscarinic acetylcholine receptor antagonist atropine (1
58 demonstrate that scopolamine, a nonselective muscarinic acetylcholine receptor antagonist, produces r
59 ve revealed that scopolamine, a nonselective muscarinic acetylcholine receptor antagonist, produces r
60 el tropane derivatives were characterized as muscarinic acetylcholine receptor antagonists (mAChRs).
62 studies show that systemic administration of muscarinic acetylcholine receptor antagonists selectivel
63 piperazines was discovered as highly potent muscarinic acetylcholine receptor antagonists via high t
64 l quaternary ammonium salts as highly potent muscarinic acetylcholine receptor antagonists with excel
65 waves, MC calcium transients were blocked by muscarinic acetylcholine receptor antagonists, whereas d
73 ous work has demonstrated that activation of muscarinic acetylcholine receptors at the lizard neuromu
74 rs (mGluRs, alpha1 adrenergic receptors, and muscarinic acetylcholine receptors), attained by superfu
75 um anti-Ro/SSA, anti-La/SSB, and anti-type 3 muscarinic acetylcholine receptor autoantibodies or in t
77 her syndrome was due to autoimmunity against muscarinic acetylcholine receptors, blocking their activ
78 It is concluded that muscarine acts on M3 muscarinic acetylcholine receptors both to inhibit IK(SO
79 is implicated in reward, whereas blockade of muscarinic acetylcholine receptors by scopolamine suppre
80 protein-coupled receptors, including the M3 muscarinic acetylcholine receptor, can form homo-oligome
84 CRT attenuated the increased M2 subtype of muscarinic acetylcholine receptor expression and Galphai
85 The patches are matched to a pattern of M2 muscarinic acetylcholine receptor expression at fixed lo
86 Galphai coupling and enhanced M3 subtype of muscarinic acetylcholine receptor expression in associat
87 /AL border coincides with a change in type 2 muscarinic acetylcholine receptor expression in layer 4
88 ic receptor is the most recent member of the muscarinic acetylcholine receptor family (M(1)-M(5)) to
91 mine (NMS) bind to the binding pocket of the muscarinic acetylcholine receptor formed by transmembran
93 resynaptic signaling pathway composed of the muscarinic acetylcholine receptor GAR-3, the heterotrime
95 ric modulators (PAMs) of the M(1) subtype of muscarinic acetylcholine receptor have emerged as an exc
96 uggest that selective activators of the M(4) muscarinic acetylcholine receptor have potential as a no
98 is known about the physiological function of muscarinic acetylcholine receptors in learning in adult
101 ity, which we tentatively have called MARIA (muscarinic acetylcholine receptor-inducing activity) is
105 acterized GPCRs coupled to either G(q) (M(1) muscarinic acetylcholine receptor (M(1)AchR) and P2y(1)
106 on) address this question in relation to the muscarinic acetylcholine receptor (M(1)AchR) and the B(2
108 lar location of NKCC1, Na(+)-K(+)-ATPase, M3 muscarinic acetylcholine receptor (M(3)AChR) and lysosom
109 e prospectively apply our model to the human muscarinic acetylcholine receptor M1, finding four exper
110 itive allosteric modulators (PAMs) of the M1 muscarinic acetylcholine receptor (M1 mAChR) are a promi
111 sed biosensor to detect activation of the M1 muscarinic acetylcholine receptor (M1 mAChR) in vitro an
112 acetylcholine receptors, particularly the M1 muscarinic acetylcholine receptor (M1 mAChR), which was
114 an be recapitulated with blockade of M1-type muscarinic acetylcholine receptors (M1-AChR); however, t
115 Galphaq-coupled receptors, including the M1 muscarinic acetylcholine receptor (M1R), and opposes the
116 consistent with beta-arrestin binding to M1 muscarinic acetylcholine receptors (M1Rs) in two differe
117 tween polymorphisms in the gene encoding the muscarinic acetylcholine receptor M2 (CHRM2) and EROs.
121 for several allosteric modulators of the M2 muscarinic acetylcholine receptor (M2 receptor), a proto
122 G betagamma), and efficiently translate M(2) muscarinic acetylcholine receptor (M2R) activation into
127 Human acini preferentially expressed the muscarinic acetylcholine receptor M3 and maintained phys
128 gical interventions, we demonstrate that the muscarinic acetylcholine receptor M3 mediates these acti
129 ed inflammatory cytokines and decreased M3R (Muscarinic Acetylcholine receptor M3) and AQP5 (Aquapori
130 major role in the regulation of the human M3 muscarinic acetylcholine receptor (M3 mAChR) in the huma
132 ts, CCK-8 and gastrin, and an agonist for m3 muscarinic acetylcholine receptors (m3 AchR), carbachol.
134 levels of AuAbs to desmocollin 3 (Dsc3), M3 muscarinic acetylcholine receptor (M3AR), and secretory
135 f family A GPCR dimers, we used the rat M(3) muscarinic acetylcholine receptor (M3R) as a model syste
136 (SMG), production of antinuclear and anti-M3 muscarinic acetylcholine receptor (M3R) autoantibodies a
138 d light on this issue, we have used the M(3) muscarinic acetylcholine receptor (M3R), a prototypic cl
139 ionally critical amino acids in the rat M(3) muscarinic acetylcholine receptor (M3R), a prototypic cl
140 To address this issue, we used the M(3) muscarinic acetylcholine receptor (M3R), a prototypic cl
142 that autoantibodies reactive with the type 3 muscarinic acetylcholine receptors (M3Rs) expressed on s
143 L to modulate the activity of beta-cell M(3) muscarinic acetylcholine receptors (M3Rs), which play an
145 the phosphorylation and regulation of the M3 muscarinic acetylcholine receptor (mACh) endogenously ex
146 itive allosteric modulators (PAMs) of the M1 muscarinic acetylcholine receptor (mAChR) achieve exquis
148 ation of vestibular afferents is mediated by muscarinic acetylcholine receptor (mAChR) activation and
150 e identity of signaling elements that couple muscarinic acetylcholine receptor (mAChR) activation to
151 on populations are differentially engaged by muscarinic acetylcholine receptor (mAChR) activation.
152 mulating evidence suggests that selective M4 muscarinic acetylcholine receptor (mAChR) activators may
154 ) protein-coupled receptors such as the M(2) muscarinic acetylcholine receptor (mAChR) and A(1) adeno
155 fibers, we investigated the function of the muscarinic acetylcholine receptor (mAchR) and G(alpha)q.
157 series of novel 1,4-dioxane analogues of the muscarinic acetylcholine receptor (mAChR) antagonist 2 w
158 X-198321) is a single molecule composed of a muscarinic acetylcholine receptor (mAChR) antagonist moi
162 pe-selective allosteric modulators of the M5 muscarinic acetylcholine receptor (mAChR) have been desc
163 t deficits in signaling of the M1 subtype of muscarinic acetylcholine receptor (mAChR) in the prefron
164 ue, we have found that the density of atrial muscarinic acetylcholine receptor (mAChR) increases with
165 siccating environmental stress with systemic muscarinic acetylcholine receptor (mAChR) inhibition.
167 Here, the extracellular vestibule of the M2 muscarinic acetylcholine receptor (mAChR) is targeted fo
168 rallel synthesis effort identified the first muscarinic acetylcholine receptor (mAChR) negative allos
169 es alpha activity when the actions of either muscarinic acetylcholine receptor (mAChR) or metabotropi
170 Novel bitopic hybrids, based on the M1/M4 muscarinic acetylcholine receptor (mAChR) orthosteric ag
174 We demonstrate that a G alpha(q)-coupled muscarinic acetylcholine receptor (mAChR) signaling path
176 positive allosteric modulation (PAM) of the muscarinic acetylcholine receptor (mAChR) subtype 5 (M5)
180 77-LH-28-1 are selective agonists of the M1 muscarinic acetylcholine receptor (mAChR) that may gain
183 sitive allosteric modulator (PAM) for the M1 muscarinic acetylcholine receptor (mAChR), but it posses
184 t manner, some receptors, including the M(2) muscarinic acetylcholine receptor (mAChR), can also exhi
193 2) purinergic receptors and transfected M(3) muscarinic acetylcholine receptors (mAChR) in Chinese ha
196 eceptors (AR) in BF; and AC5/6, beta1-AR, M4-muscarinic acetylcholine receptors (mAChR), mu-opioid re
198 tory learning in adult flies requires type A muscarinic acetylcholine receptors (mAChR-A), particular
199 this study we showed that stimulation of M1 muscarinic acetylcholine receptors (mAChRs) activates en
203 duced by mamba snakes that primarily bind to muscarinic acetylcholine receptors (MAChRs) and modulate
206 s to determine the extent to which m1 and m2 muscarinic acetylcholine receptors (mAChRs) are expresse
207 cotinic acetylcholine receptors (nAChRs) and muscarinic acetylcholine receptors (mAChRs) are expresse
214 re, we show that physiological activation of muscarinic acetylcholine receptors (mAChRs) controls the
217 y transmission mediated, for example, by the muscarinic acetylcholine receptors (mAChRs) in relevant
223 gency and frequency, presumably by acting on muscarinic acetylcholine receptors (mAChRs) located in b
224 at subtype-selective activators of M(1)/M(4) muscarinic acetylcholine receptors (mAChRs) may offer a
225 elective antagonists of specific subtypes of muscarinic acetylcholine receptors (mAChRs) may provide
234 cholinergic innervation from the septum, and muscarinic acetylcholine receptors (mAChRs) share some s
236 etabotropic glutamate receptors (mGluRs) and muscarinic acetylcholine receptors (mAChRs) synergistica
237 rugs (DREADDs) are chemogenetically modified muscarinic acetylcholine receptors (mAChRs) that have mi
239 endent mechanisms, whereas others, like M(2) muscarinic acetylcholine receptors (mAChRs), are interna
240 We also characterized two types (A and B) of muscarinic acetylcholine receptors (mAChRs), which were
246 ution of BK channels to control of M2- or M3-muscarinic acetylcholine receptor mediated airway smooth
247 CIH-induced HIF-alpha isoform imbalance via muscarinic acetylcholine receptor-mediated Ca(2+) influx
248 er suggests that GRK2 may selectively impair muscarinic acetylcholine receptor-mediated function in v
249 ts also potentiated both opioid receptor and muscarinic acetylcholine receptor-mediated stimulation o
250 luorescently labeled dibenzodiazepinone-type muscarinic acetylcholine receptor (MR) antagonists, incl
254 ly, signaling and function mediated by m2/m3 muscarinic acetylcholine receptors or prostaglandin E(2)
255 ere agonist binding follows hyperbolic (M(4) muscarinic acetylcholine receptors) or nonhyperbolic rel
256 when activated via either the endogenous M3 muscarinic acetylcholine receptor, or via coexpressed mG
257 lternative strategy is to selectively target muscarinic acetylcholine receptors, particularly the M1
258 Additionally, blocking nicotinic, but not muscarinic, acetylcholine receptors prevents SCC-mediate
260 report that activation of the M4 subtype of muscarinic acetylcholine receptor reduces transmission a
266 g pattern of geniculocortical inputs with M2 muscarinic acetylcholine receptor-rich patches in layer
267 tractile GPCRs, but selectively inhibited M3 muscarinic acetylcholine receptor signaling ( approximat
268 has important functions in both hippocampal muscarinic acetylcholine receptor signalling and in cort
269 agonist-bound, active state of the human M2 muscarinic acetylcholine receptor stabilized by a G-prot
270 otype previously used for the preparation of muscarinic acetylcholine receptor subtype 1 positive all
273 ubstantia nigra pars reticulata (SNr) act on muscarinic acetylcholine receptor subtype 4 (M4) to oppo
274 f the first positive allosteric modulator of muscarinic acetylcholine receptor subtype 5 (mAChR5 or M
275 Mice with targeted disruption of single muscarinic acetylcholine receptor subtype genes (M(1) to
276 t mutant mice that selectively lack the M(3) muscarinic acetylcholine receptor subtype in the brain (
281 gG reactivity in patients with PV toward the muscarinic acetylcholine receptor subtypes 3, 4, and 5 a
283 tant versions of bovine rhodopsin and the M3 muscarinic acetylcholine receptor suggested that the cyt
284 diolabeled species from all five subtypes of muscarinic acetylcholine receptors, suggesting allosteri
285 tion of Gq-coupled receptors, such as the m1 muscarinic acetylcholine receptor, suppresses the M-curr
286 enous actuator ligand to activate a modified muscarinic acetylcholine receptor that is insensitive to
291 c stimulation of the heart acts through M(2)-muscarinic acetylcholine receptors to regulate ion chann
292 imary and secondary Gi/o coupling, using the muscarinic acetylcholine receptor type 2 (M2R) as the pr
293 ex can inhibit Ca2+ mobilization elicited by muscarinic acetylcholine receptor type 3 (M3R), but not
294 CIN firing by CRF results in the activation muscarinic acetylcholine receptors type 5, which mediate
296 ion depended on local activation of cortical muscarinic acetylcholine receptors, whereas the increase
298 macotherapy with nonselective antagonists of muscarinic acetylcholine receptors, which have many unde
299 nous activation of metabotropic glutamate or muscarinic acetylcholine receptors with submaximal TBF u